Parkon® in the treatment of multiple sclerosis. A pilot study

<p>Multiple Sclerosis (MS) is one of the most common chronic demyelinating diseases of the central nervous system. The disease affects and relatively quickly leads to disability in mainly people 15-40 years of age. The development of MS can occur progressively or with exacerbations and remissi...

詳細記述

保存先:
書誌詳細
主要な著者: Goldstein NI (著者), Golubev VL (著者), Goldstein RN (著者)
フォーマット: 図書
出版事項: Open Journal of Parkinson's Disease and Treatment - Peertechz Publications, 2020-08-07.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可